risedronate sodium 5 MG Oral Tablet

RxCUI
905041
RxNorm name
risedronate sodium 5 MG Oral Tablet
Display name
risedronate sodium 5 MG Oral Tablet
Full name
risedronate sodium 5 MG Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:50

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 5 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Risedronate SodiumRISEDRONATE SODIUMTeva Pharmaceuticals USA, Inc.dddcd321-4d2e-4643-bf3c-7b752b33ba392026-03-30Warnings, Adverse reactionsExact identifier
rxcui: 905041
Risedronate SodiumRISEDRONATE SODIUMMacleods Pharmaceuticals Limited62aff8d6-a2f7-4c7e-a102-c70105ac37922026-03-01Warnings, Adverse reactionsExact identifier
rxcui: 905041
risedronate sodiumRISEDRONATE SODIUMSun Pharmaceutical Industries, Inc.e0b5f0ed-ff40-4f0d-bb86-81a7ace9f3392026-02-17Warnings, Adverse reactionsExact identifier
rxcui: 905041
Risedronate SodiumRISEDRONATE SODIUMAurobindo Pharma Limited89896dfe-f69d-4cb3-bb71-7a7c611071fa2026-02-11Warnings, Adverse reactionsExact identifier
rxcui: 905041
ActonelRISEDRONATE SODIUMAllergan, Inc.24ed00e0-25e2-49a8-97fc-66c1b417dc0b2026-02-04Warnings, Adverse reactionsExact identifier
rxcui: 905041

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 6 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
24ed00e0-25e2-49a8-97fc-66c1b417dc0brisedronate sodium 5 MG Oral Tablet [PSN] · risedronate sodium 5 MG Oral Tablet [SCD]231These highlights do not include all the information needed to use ACTONEL safely and effectively. See full prescribing information for ACTONEL. ACTONEL ® ( risedronate sodium ) tablets , for oral use Initial U.S. Approval: 199 820260204
e0b5f0ed-ff40-4f0d-bb86-81a7ace9f339risedronate sodium 5 MG Oral Tablet [PSN] · risedronate sodium 5 MG Oral Tablet [SCD]217These highlights do not include all the information needed to use RISEDRONATE SODIUM TABLETS safely and effectively. See Full Prescribing Information for RISEDRONATE SODIUM TABLETS. RISEDRONATE SODIUM tablets, for oral use Initial U.S. Approval: 199820260217
dddcd321-4d2e-4643-bf3c-7b752b33ba39risedronate sodium 5 MG Oral Tablet [PSN] · risedronate sodium 5 MG Oral Tablet [SCD]215These highlights do not include all the information needed to use RISEDRONATE SODIUM TABLETS safely and effectively. See full prescribing information for RISEDRONATE SODIUM TABLETS . RISEDRONATE SODIUM tablets, for oral use Initial U.S. Approval: 199820260330
62aff8d6-a2f7-4c7e-a102-c70105ac3792risedronate sodium 5 MG Oral Tablet [PSN] · risedronate sodium 5 MG Oral Tablet [SCD]29These highlights do not include all the information needed to use RISEDRONATE SODIUM TABLETS safely and effectively. See Full Prescribing Information for RISEDRONATE SODIUM TABLETS. RISEDRONATE SODIUM tablets, USP, for oral use Initial U.S. Approval: 199820260301
89896dfe-f69d-4cb3-bb71-7a7c611071farisedronate sodium 5 MG Oral Tablet [PSN] · risedronate sodium 5 MG Oral Tablet [SCD]29These highlights do not include all the information needed to use RISEDRONATE SODIUM TABLETS safely and effectively. See Full Prescribing Information for RISEDRONATE SODIUM TABLETS. RISEDRONATE SODIUM tablets, for oral use Initial U.S. Approval: 199820260211
4423d70a-b120-4653-bcf3-0c5ea8b97b0erisedronate sodium 5 MG Oral Tablet [PSN] · risedronate sodium 5 MG Oral Tablet [SCD]22These highlights do not include all the information needed to use ACTONEL safely and effectively. See full prescribing information for ACTONEL. ACTONEL ® (risedronate sodium) tablets Initial U.S. Approval: 199820100324